Lymphocyte mitochondrial biomarkers in asymptomatic HIV-1-infected individuals treated with nucleoside reverse transcriptase inhibitors
- 1 December 2002
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 16 (18) , 2485-2487
- https://doi.org/10.1097/00002030-200212060-00018
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Changes in Mitochondrial DNA as a Marker of Nucleoside Toxicity in HIV-Infected PatientsNew England Journal of Medicine, 2002
- Analysis of the mitochondrial DNA genome in the peripheral blood leukocytes of HIV-infected patients with or without lipoatrophyAIDS, 2002
- Mitochondrial Functionality and Mitochondrial DNA Content in Lymphocytes of Vertically Infected Human Immunodeficiency Virus–Positive Children with Highly Active Antiretroviral Therapy–Related LipodystrophyThe Journal of Infectious Diseases, 2002
- Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophyAIDS, 2001
- A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndromeAIDS, 2000
- Nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity as an etiology for lipodystrophyAIDS, 1999
- Adverse effects of reverse transcriptase inhibitorsAIDS, 1998
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998